📌 Key Takeaways
- Topic: Silica as a Desiccant: Moisture Capacity, Types and Uses
- Keywords: diatomaceous earth
- Published: 2026-11-20 07:06:29
- Field: Silica (SiO₂) raw materials · Inorganic non-metallic materials · Chemicals
Silica Mesh Size Chart: Mesh to Micron Conversion and How to Choose
- Crystalline Silica Powder: Grades, Uses and Safe Handling Requirements
- 39. Kim D., Koo J., Yang E.-J., Shim K., Tin Y.Y., Lin Z., Oh K.T., Na D.H. Entrapment of celecoxib into mesoporous silica particles for tablets with improved dissolution through amorphization. J. Drug Deliv. Sci. Technol. 2023;84:104485. doi: 10.1016/j.jddst.2023.104485. [ DOI ] [ Google Scholar ]
- What Is Hydrophobic Fumed Silica? Surface Treatment, Grades and Applications
- 21. Talekar S., Dave R. Solubility Enhancement of a BCS Class II Drug Employing Granulated Fumed Silica as an Adsorbent. J. Pharm. Res. Int. 2017;18:1-15. doi: 10.9734/JPRI/2017/36872. [ DOI ] [ Google Scholar ]
- How to Disperse Fumed Silica: Methods, Equipment and Common Mistakes
- What Is Modified Silica? Surface Modification Methods and Performance Benefits
Is Silicon Dioxide Safe? What Science and Regulators Say
What is silica (SiO₂)?
is silicon dioxide toxic Keywords: mesoporous silica, nanoparticles, drug delivery, toxicity, functionalization, stimuli-responsive
What is the difference between fumed silica and precipitated silica?
silicon dioxide physical properties 6. Drug Administration
What drives silica raw material prices?
silica for chromatography Nanoparticles (NPs) would naturally encounter some difficulties in accessing ideal targets. They can be deposited in non-target tissues due to physiological barriers, heterogeneity of receptor expression, and defective targeting mechanisms, and therefore become potentially toxic and less effective [ 80 ]. In addition, environment-sensitive systems responsive to environmental stimuli such as pH may be activated before their intended use, or in normal tissues if the same environmental circumstances are present, leading to unwanted release of the drug [ 81 ]. Biological heterogeneity of patients, i.e., immune factors such as anti-PEG antibodies, may influence the biodistribution of nanoparticles and off-target interactions as well [ 80 ].
/news/article.htmlDisclaimer: Prices and data are for reference only and do not constitute purchasing or investment advice. Please credit the source when republishing.